COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,415,500 | -61.4% | 1,226,142 | -37.7% | 1.01% | -32.5% |
| Q2 2023 | $6,262,361 | -12.0% | 1,969,296 | -9.5% | 1.50% | -23.9% |
| Q1 2023 | $7,118,927 | -36.5% | 2,177,042 | -2.4% | 1.96% | -59.3% |
| Q4 2022 | $11,219,000 | +300.0% | 2,230,441 | +81.3% | 4.83% | +364.3% |
| Q3 2022 | $2,805,000 | -14.0% | 1,230,441 | 0.0% | 1.04% | -12.4% |
| Q2 2022 | $3,261,000 | +87.4% | 1,230,441 | -3.1% | 1.19% | +135.5% |
| Q1 2022 | $1,740,000 | -72.6% | 1,270,211 | -36.5% | 0.50% | -67.8% |
| Q4 2021 | $6,340,000 | – | 2,000,000 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 4,400,000 | $22,132,000 | 17.19% |
| Monashee Investment Management LLC | 2,230,441 | $11,219,000 | 4.83% |
| CHI Advisors LLC | 2,829,712 | $14,233,452 | 3.79% |
| CAXTON CORP | 211,159 | $1,062,132 | 2.71% |
| Orbimed Advisors | 22,362,850 | $112,485,136 | 2.15% |
| Vivo Capital, LLC | 3,557,630 | $17,895 | 2.06% |
| DAFNA Capital Management LLC | 602,051 | $3,028,316 | 0.85% |
| Rock Springs Capital Management LP | 5,333,188 | $26,825,936 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 268,307 | $1,349,584 | 0.39% |
| BRAIDWELL LP | 1,814,266 | $9,125,758 | 0.31% |